September 5, 2023 Quanterix to Participate at the Morgan Stanley 21st Annual Global Healthcare Conference read more
July 31, 2023 Quanterix’s Simoa® Technology Powers Large, International Reference Range Study Utilizing Serum Neurofilament Light (sNfL) to Assess Neurological Disease Activity in Pediatric Patients read more
July 6, 2023 Quanterix Launches LucentAD Biomarker Blood Test to Aid Physician Diagnosis of Alzheimer’s Disease in Patients read more
June 7, 2023 Quanterix to Participate in Fireside Chat at Goldman Sachs Annual Global Healthcare Conference read more